Tectonic Therapeutic Inc (TECX) concluded trading on Thursday at a closing price of $54.84, with 5.54 million shares of worth about $303.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 204.67% during that period and on January 30, 2025 the price saw a gain of about 113.22%. Currently the company’s common shares owned by public are about 14.74M shares, out of which, 7.78M shares are available for trading.
Stock saw a price change of 29.95% in past 5 days and over the past one month there was a price change of 16.61%. Year-to-date (YTD), TECX shares are showing a performance of 18.78% which increased to 233.58% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $12.12 but also hit the highest price of $53.41 during that period. The average intraday trading volume for Tectonic Therapeutic Inc shares is 144.20K. The stock is currently trading 30.92% above its 20-day simple moving average (SMA20), while that difference is up 21.64% for SMA50 and it goes to 98.54% higher than SMA200.
Tectonic Therapeutic Inc (NASDAQ: TECX) currently have 14.74M outstanding shares and institutions hold larger chunk of about 34.77% of that.
The stock has a current market capitalization of $809.04M and its 3Y-monthly beta is at 1.14. It has posted earnings per share of -$9.73 in the same period. It has Quick Ratio of 9.39 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TECX, volatility over the week remained 48.65% while standing at 17.08% over the month.
Stock’s fiscal year EPS is expected to rise by 55.24% while it is estimated to increase by 35.14% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on November 20, 2024 offering an Outperform rating for the stock and assigned a target price of $65 to it. Coverage by Wells Fargo stated Tectonic Therapeutic Inc (TECX) stock as an Overweight in their note to investors on August 22, 2024, suggesting a price target of $55 for the stock. Stock get a Neutral rating from Mizuho on December 18, 2023.
